Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities.

MLA

Patoulias, Dimitrios, et al. “Unraveling the Safety and Efficacy of Semaglutide for People Living with HIV and Metabolic Co-Morbidities.” Expert Opinion on Drug Safety, vol. 24, no. 2, Feb. 2025, pp. 121–24. EBSCOhost, https://doi.org/10.1080/14740338.2024.2435426.

APA

Patoulias, D., Karakasis, P., Ruža, I., El-Tanani, M., & Rizzo, M. (2025). Unraveling the safety and efficacy of semaglutide for people living with HIV and metabolic co-morbidities. Expert Opinion on Drug Safety, 24(2), 121–124. https://doi.org/10.1080/14740338.2024.2435426

Chicago

Patoulias, Dimitrios, Paschalis Karakasis, Ieva Ruža, Mohamed El-Tanani, and Manfredi Rizzo. 2025. “Unraveling the Safety and Efficacy of Semaglutide for People Living with HIV and Metabolic Co-Morbidities.” Expert Opinion on Drug Safety 24 (2): 121–24. doi:10.1080/14740338.2024.2435426.